\-\ Texto\\:\\ \ \(0\)\
\-\ bilateral\\ lower\\ extremity\\ weakness\\ and\\ decreased\\ sensation\\.\ \(0\)\
\-\ surgical\\ resection\\.\ \(23\)\
\-\ hypointense\\ \\(relative\\ to\\ cord\\,\\ t1\\)\\ filum\\ terminale\\ mass\\ lesion\\ occupying\\ the\\ entire\\ central\\ canal\\.\\ \\ heterogenous\\ appearing\\ on\\ t2\\,\\ ranging\\ from\\ iso\\-\\ to\\ slightly\\ hyperintense\\ \\(relative\\ to\\ cord\\)\\.\\ \\ strong\\ but\\ slightly\\ heterogenous\\ enhancement\\.\ \(0\)\
\-\ filum\\ terminale\\ myxopapillary\\ ependymoma\ \(0\)\
\-\ schwannoma\ \(67\)\
\-\ meningioma\ \(167\)\
\-\ paragaglioma\ \(0\)\
\-\ drop\\ mets\ \(2\)\
\-\ 16\\ year\\ old\\ male\\ with\\ bilaterally\\ symmetrical\\ low\\ back\\ pain\\ progressing\\ to\\ weakness\\ and\\ decreased\\ sensation\\ in\\ lower\\ extremities\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ filum\\:\\ 0\\.1584598308930402\ \(0\)\
\-\ terminale\\:\\ 0\\.1584598308930402\ \(0\)\
\-\ paragaglioma\\:\\ 0\\.10883356078970985\ \(0\)\
\-\ heterogenous\\:\\ 0\\.10826423765736257\ \(0\)\
\-\ relative\\:\\ 0\\.10050830359514193\ \(0\)\
\-\ sensation\\:\\ 0\\.09691776038875911\ \(0\)\
\-\ slightly\\:\\ 0\\.08528953724091537\ \(0\)\
\-\ myxopapillary\\:\\ 0\\.08170733143987997\ \(0\)\
\-\ cord\\:\\ 0\\.08017713383223213\ \(0\)\
\-\ iso\\-\\:\\ 0\\.0792299154465201\ \(0\)\
\-\ weakness\\:\\ 0\\.078360774148849\ \(0\)\
\-\ ranging\\:\\ 0\\.0724824622814822\ \(0\)\
\-\ progressing\\:\\ 0\\.06959832831627842\ \(0\)\
\-\ symmetrical\\:\\ 0\\.06814421676496504\ \(0\)\
\-\ occupying\\:\\ 0\\.06566680077160515\ \(0\)\
\-\ drop\\:\\ 0\\.0649403748453961\ \(0\)\
\-\ decreased\\:\\ 0\\.062734725993199\ \(0\)\
\-\ strong\\:\\ 0\\.06130087434884493\ \(0\)\
\-\ mets\\:\\ 0\\.060786396615504584\ \(0\)\
\-\ entire\\:\\ 0\\.05185676428549677\ \(0\)\
\-\ hypointense\\:\\ 0\\.05004128998973755\ \(0\)\
\-\ schwannoma\\:\\ 0\\.04818350047198082\ \(0\)\
\-\ 16\\:\\ 0\\.04773775967392999\ \(0\)\
\-\ lower\\:\\ 0\\.047453384428737345\ \(0\)\
\-\ ependymoma\\:\\ 0\\.04722328194058965\ \(0\)\
\-\ appearing\\:\\ 0\\.04689183440927868\ \(0\)\
\-\ hyperintense\\:\\ 0\\.04379827487534778\ \(0\)\
\-\ canal\\:\\ 0\\.04191337561350879\ \(0\)\
\-\ extremities\\:\\ 0\\.04137884714741837\ \(0\)\
\-\ meningioma\\:\\ 0\\.04056900415376635\ \(0\)\
\-\ extremity\\:\\ 0\\.03858220950175849\ \(0\)\
\-\ back\\:\\ 0\\.034803288090709594\ \(0\)\
\-\ central\\:\\ 0\\.034711498232839\ \(0\)\
\-\ bilaterally\\:\\ 0\\.034650681957085226\ \(0\)\
\-\ t1\\:\\ 0\\.0334382164965956\ \(0\)\
\-\ resection\\:\\ 0\\.03290019327802739\ \(0\)\
\-\ t2\\:\\ 0\\.029859120601856196\ \(0\)\
\-\ low\\:\\ 0\\.029335408060079005\ \(0\)\
\-\ enhancement\\:\\ 0\\.028277639087938716\ \(0\)\
\-\ bilateral\\:\\ 0\\.0256026880162277\ \(0\)\
\-\ but\\:\\ 0\\.022500040753500462\ \(0\)\
\-\ surgical\\:\\ 0\\.022175577410511772\ \(0\)\
\-\ lesion\\:\\ 0\\.0214883361234624\ \(0\)\
\-\ to\\:\\ 0\\.021089783132986973\ \(0\)\
\-\ male\\:\\ 0\\.01907661157885769\ \(0\)\
\-\ \\(\\:\\ 0\\.017836092006021247\ \(0\)\
\-\ \\)\\:\\ 0\\.017618214620081608\ \(0\)\
\-\ from\\:\\ 0\\.01563500880437299\ \(0\)\
\-\ mass\\:\\ 0\\.014672358110463758\ \(0\)\
\-\ pain\\:\\ 0\\.012884051450996725\ \(0\)\
\-\ year\\:\\ 0\\.011803768756455738\ \(0\)\
\-\ old\\:\\ 0\\.010801661689657464\ \(0\)\
\-\ on\\:\\ 0\\.008936926078585532\ \(0\)\
\-\ \\,\\:\\ 0\\.006684199148574997\ \(0\)\
\-\ in\\:\\ 0\\.005202434940003147\ \(0\)\
\-\ and\\:\\ 0\\.004444666808202925\ \(0\)\
\-\ \\.\\:\\ 0\\.0026295952664700945\ \(0\)\
\-\ the\\:\\ 0\\.0017067812926373554\ \(0\)\
\-\ with\\:\\ 0\\.0014444960011097499\ \(0\)\
